Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 380

    1.

    Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain.

    Inoue M, Ma L, Aoki J, Chun J, Ueda H.

    Mol Pain. 2008 Feb 8;4:6.PMID: 18261210 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid.

    Inoue M, Xie W, Matsushita Y, Chun J, Aoki J, Ueda H.

    Neuroscience. 2008 Mar 18;152(2):296-8. Epub 2008 Jan 9.PMID: 18280050 [PubMed - indexed for MEDLINE]Related articles

    3.

    Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain.

    Inoue M, Ma L, Aoki J, Ueda H.

    J Neurochem. 2008 Dec;107(6):1556-65. Epub 2008 Nov 5.PMID: 19014389 [PubMed - indexed for MEDLINE]Related articles

    4.

    Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.

    Ma L, Uchida H, Nagai J, Inoue M, Chun J, Aoki J, Ueda H.

    Mol Pain. 2009 Nov 13;5(1):64. [Epub ahead of print]PMID: 19912636 [PubMed - as supplied by publisher]Related articlesFree article

    5.

    Two pathways for lysophosphatidic acid production.

    Aoki J, Inoue A, Okudaira S.

    Biochim Biophys Acta. 2008 Sep;1781(9):513-8. Epub 2008 Jun 24. Review.PMID: 18621144 [PubMed - indexed for MEDLINE]Related articles

    6.

    Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development.

    van Meeteren LA, Ruurs P, Stortelers C, Bouwman P, van Rooijen MA, Pradère JP, Pettit TR, Wakelam MJ, Saulnier-Blache JS, Mummery CL, Moolenaar WH, Jonkers J.

    Mol Cell Biol. 2006 Jul;26(13):5015-22.PMID: 16782887 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Profiling of BoNT/C3-reversible gene expression induced by lysophosphatidic acid: ephrinB1 gene up-regulation underlying neuropathic hyperalgesia and allodynia.

    Uchida H, Matsumoto M, Ueda H.

    Neurochem Int. 2009 Mar-Apr;54(3-4):215-21. Epub 2008 Dec 7.PMID: 19111589 [PubMed - indexed for MEDLINE]Related articles

    8.

    Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1.

    Hama K, Aoki J, Fukaya M, Kishi Y, Sakai T, Suzuki R, Ohta H, Yamori T, Watanabe M, Chun J, Arai H.

    J Biol Chem. 2004 Apr 23;279(17):17634-9. Epub 2004 Jan 26.PMID: 14744855 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Reduced nerve injury-induced neuropathic pain in kinin B1 receptor knock-out mice.

    Ferreira J, Beirith A, Mori MA, Araújo RC, Bader M, Pesquero JB, Calixto JB.

    J Neurosci. 2005 Mar 2;25(9):2405-12.PMID: 15745967 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Therapeutic potential of autotaxin/lysophospholipase d inhibitors.

    Federico L, Pamuklar Z, Smyth SS, Morris AJ.

    Curr Drug Targets. 2008 Aug;9(8):698-708. Review.PMID: 18691016 [PubMed - indexed for MEDLINE]Related articles

    11.

    Regulation and biological activities of the autotaxin-LPA axis.

    van Meeteren LA, Moolenaar WH.

    Prog Lipid Res. 2007 Mar;46(2):145-60. Epub 2007 Mar 16. Review.PMID: 17459484 [PubMed - indexed for MEDLINE]Related articles

    12.

    Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions.

    Nakasaki T, Tanaka T, Okudaira S, Hirosawa M, Umemoto E, Otani K, Jin S, Bai Z, Hayasaka H, Fukui Y, Aozasa K, Fujita N, Tsuruo T, Ozono K, Aoki J, Miyasaka M.

    Am J Pathol. 2008 Nov;173(5):1566-76. Epub 2008 Sep 25.PMID: 18818380 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid.

    Tanaka M, Okudaira S, Kishi Y, Ohkawa R, Iseki S, Ota M, Noji S, Yatomi Y, Aoki J, Arai H.

    J Biol Chem. 2006 Sep 1;281(35):25822-30. Epub 2006 Jul 6.PMID: 16829511 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Activation of extracellular signal-regulated kinase in sciatic nerve contributes to neuropathic pain after partial sciatic nerve ligation in mice.

    Kiguchi N, Maeda T, Kobayashi Y, Fukazawa Y, Kishioka S.

    Anesth Analg. 2009 Oct;109(4):1305-11.PMID: 19762761 [PubMed - indexed for MEDLINE]Related articles

    15.

    Loss of spinal substance P pain transmission under the condition of LPA1 receptor-mediated neuropathic pain.

    Inoue M, Yamaguchi A, Kawakami M, Chun J, Ueda H.

    Mol Pain. 2006 Aug 16;2:25.PMID: 16914035 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Nerve injury induces a tonic bilateral mu-opioid receptor-mediated inhibitory effect on mechanical allodynia in mice.

    Mansikka H, Zhao C, Sheth RN, Sora I, Uhl G, Raja SN.

    Anesthesiology. 2004 Apr;100(4):912-21.PMID: 15087627 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid.

    Kishi Y, Okudaira S, Tanaka M, Hama K, Shida D, Kitayama J, Yamori T, Aoki J, Fujimaki T, Arai H.

    J Biol Chem. 2006 Jun 23;281(25):17492-500. Epub 2006 Apr 19.PMID: 16627485 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure.

    Panchatcharam M, Miriyala S, Yang F, Rojas M, End C, Vallant C, Dong A, Lynch K, Chun J, Morris AJ, Smyth SS.

    Circ Res. 2008 Sep 12;103(6):662-70. Epub 2008 Aug 14.PMID: 18703779 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: relevance to prostate cancer and benign hyperplasia.

    Zeng Y, Kakehi Y, Nouh MA, Tsunemori H, Sugimoto M, Wu XX.

    Prostate. 2009 Feb 15;69(3):283-92.PMID: 19025891 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data